EQL Pharma is a generics- and speciality pharma company, dedicated to providing cost efficient pharmaceuticals for the Nordic markets. This is accomplished with the highest quality standards and streamlined logistic solutions.
The Nomination Committee for the Annual General Meeting in 2016
In accordance with a resolution from the 2015 Annual General Meeting the Nomination Committee shall consist of the Chairman of the Board and one representative for each of the three largest shareholders in terms of voting rights at the end of September…
EQL Pharma enters into a strategic agreement with Cadila Pharmaceuticals Limited
EQL Pharma AB has today, entered into a strategic agreement with Cadila Pharmaceuticals Limited (Cadila Pharma). According to the agreement, EQL Pharma will: Issue 6.5 million shares to Cadila Pharma at a subscription price of SEK 5 per share, for…
EQL Pharma’s 2014 Annual Report now available
Today, EQL Pharma announced that the company’s Annual Report for 2014 is available as PDF at www.eqlpharma.com. For more information, please contact: Christer Fåhraeus CEO EQL Pharma AB Phone: +46 (0) 705 – 60 90 00 E-mail: email@example.com Website: www.eqlpharma.com…
- View all press releases